Utilizing gene expression profiling, phosphoproteomics and loss-of-function screens to enhance the therapeutic efficacy of dasatinib in glioblastoma
Saved in:
| Main Author: | |
|---|---|
| Format: | Book/Monograph Thesis |
| Language: | English |
| Published: |
Heidelberg
2022
|
| Subjects: | |
| Online Access: |
|
| Author Notes: | vorgelegt von Obada Alhalabi; Doktorvater: Herr Prof. Dr. med. Peter Lichter |
| Description not available. |